ethoglucid has been researched along with Local Neoplasm Recurrence in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (68.18) | 18.7374 |
| 1990's | 7 (31.82) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BHARDWAJ, BV; CLIFFORD, P; WHITTAKER, LR | 1 |
| HARRISON, DF | 1 |
| Ay, R; Dalesio, O; de Pauw, M; Debruyne, F; Kurth, KH; Pavone-Macaluso, M; Schröder, FH; ten Kate, F; Tunn, U | 1 |
| Lum, BL | 1 |
| Lum, BL; Torti, FM | 1 |
| Baumgartner, G | 1 |
| Fitzpatrick, JM; Khan, O; Oliver, RT; Riddle, PR | 2 |
| Colleen, S; Ek, A; Hellsten, S; Lindholm, CE | 1 |
| Albrecht, W; Bucher, A; Donner, G; Flamm, J; Havelec, L; Höltl, W | 1 |
| Ay, R; de Pauw, M; Debruyne, F; Kurth, K; Pavone-Macaluso, M; Schröder, FH; Sylvester, R; ten Kate, F; Tunn, U | 1 |
| Lane, V; O'Flynn, JD; SMith, JM | 1 |
| Bastable, J; Glashan, RW; Richards, B; Robinson, MR; Shetty, MB; Smith, PH | 1 |
| Debruyne, FM; Kurth, KH; Oosterlinck, W; van der Meijden, AP | 1 |
| Albrecht, W; Hasun, R; Hoeltl, W | 1 |
| Albrecht, W; Hasun, R; Hoeltl, W; Marberger, M | 1 |
| Bucher, A; Flamm, J | 1 |
| Albrecht, W; Bucher, A; Flamm, J; Höltl, W | 1 |
| Dona, S; Flamm, J; Kühnel, W | 1 |
| Carpentier, PJ; de Pauw, M; Debruyne, FJ; Kurth, KH; Riedl, H; Senge, T; Sylvester, R | 1 |
| Fritjofsson, A; Larson, A | 1 |
| Fingerhut, B; Romas, NA; Veenema, RJ | 1 |
4 review(s) available for ethoglucid and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Intravesical chemotherapy of superficial bladder cancer.
Topics: Absorption; Animals; Antineoplastic Agents; BCG Vaccine; Carcinoma in Situ; Doxorubicin; Endoscopy; Ethoglucid; Humans; Hydrogen-Ion Concentration; Mitomycin; Mitomycins; Molecular Weight; Neoplasm Recurrence, Local; Teniposide; Thiotepa; Urinary Bladder Neoplasms | 1983 |
The biology and treatment of superficial bladder cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; BCG Vaccine; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Combined Modality Therapy; Cystoscopy; Doxorubicin; Ethoglucid; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Prognosis; Teniposide; Thiotepa; Urinary Bladder; Urinary Bladder Neoplasms | 1984 |
[Progress in the internist treatment of bladder tumors].
Topics: Antineoplastic Agents; BCG Vaccine; Cisplatin; Doxorubicin; Ethoglucid; Humans; Leucovorin; Methotrexate; Mitomycins; Neoplasm Metastasis; Neoplasm Recurrence, Local; Teniposide; Thiotepa; Urinary Bladder Neoplasms | 1982 |
Chemotherapy for bladder cancer.
Topics: Administration, Topical; Alkylating Agents; Blood Cell Count; Carcinoma, Papillary; Cystitis; Cystoscopy; Ethers; Ethoglucid; Humans; Leukocyte Count; Leukopenia; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Postoperative Care; Preoperative Care; Thiotepa; Thrombocytopenia; Urinary Bladder Neoplasms; Urinary Catheterization; Urination Disorders | 1974 |
11 trial(s) available for ethoglucid and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Adjuvant chemotherapy of superficial transitional cell bladder carcinoma: preliminary results of a European organization for research on treatment of cancer. Randomized trial comparing doxorubicin hydrochloride, ethoglucid and transurethral resection alon
Topics: Carcinoma, Transitional Cell; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Ethers; Ethoglucid; Humans; Male; Methods; Neoplasm Recurrence, Local; Random Allocation; Urethra; Urinary Bladder Neoplasms | 1984 |
[Topical immunotherapy (KLH) vs. chemotherapy (Ethoglucid) in prevention of recurrence of superficial bladder cancer. A prospective randomized study].
Topics: Adjuvants, Immunologic; Administration, Intravesical; Adult; Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Combined Modality Therapy; Ethoglucid; Female; Follow-Up Studies; Hemocyanins; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Urinary Bladder Neoplasms | 1994 |
Adjuvant chemotherapy for superficial transitional cell bladder carcinoma: long-term results of a European Organization for Research and Treatment of Cancer randomized trial comparing doxorubicin, ethoglucid and transurethral resection alone.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Disease Progression; Doxorubicin; Ethoglucid; Female; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Rate; Time Factors; Urinary Bladder Neoplasms | 1997 |
Intravesical therapy with adriamycin and 4-epirubicin for superficial bladder cancer: the experience of the EORTC GU Group.
Topics: Administration, Intravesical; Chemotherapy, Adjuvant; Doxorubicin; Epirubicin; Ethoglucid; Humans; Neoplasm Recurrence, Local; Prospective Studies; Urinary Bladder Neoplasms | 1992 |
Prospective, randomized trial to evaluate high-versus low-dose interferon-alpha 2b versus conventional chemotherapy in prevention of the recurrence of superficial transitional cell carcinoma of the urinary bladder.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Drug Evaluation; Ethoglucid; Female; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Neoplasm Recurrence, Local; Recombinant Proteins; Urinary Bladder Neoplasms | 1992 |
How effective is topical alpha-2b interferon in preventing recurrence of superficial bladder cancer?
Topics: Administration, Intravesical; Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Ethoglucid; Female; Follow-Up Studies; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Neoplasm Recurrence, Local; Recombinant Proteins; Urinary Bladder Neoplasms | 1991 |
Adjuvant topical chemotherapy versus immunotherapy in primary superficial transitional cell carcinoma of the bladder.
Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Combined Modality Therapy; Ethoglucid; Female; Hemocyanins; Humans; Immunotherapy; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Risk Factors; Urinary Bladder Neoplasms | 1991 |
Recurrent superficial transitional cell carcinoma of the bladder: adjuvant topical chemotherapy versus immunotherapy. A prospective randomized trial.
Topics: Administration, Intravesical; Aged; Antigens; Carcinoma, Transitional Cell; Ethers; Ethoglucid; Female; Hemocyanins; Humans; Immunotherapy; Male; Neoplasm Recurrence, Local; Prospective Studies; Randomized Controlled Trials as Topic; Urinary Bladder Neoplasms | 1990 |
[Short-term versus long-term chemoprevention of recurrence with Epodyl following transurethral resection of superficial urinary bladder cancer].
Topics: Administration, Intravesical; Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Clinical Trials as Topic; Combined Modality Therapy; Cystoscopy; Drug Administration Schedule; Ethers; Ethoglucid; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Random Allocation; Urethra; Urinary Bladder Neoplasms | 1989 |
Adjuvant chemotherapy of superficial transitional cell carcinoma: an E.O.R.T.C. randomized trail comparing doxorubicin hydrochloride, ethoglucid and TUR-alone.
Topics: Carcinoma, Transitional Cell; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Ethers; Ethoglucid; Humans; Neoplasm Recurrence, Local; Random Allocation; Urinary Bladder Neoplasms | 1985 |
Intravesical ethoglucid (Epodyl) for treatment of noninvasive bladder cancer (stage Ta).
Topics: Adult; Aged; Clinical Trials as Topic; Ethers; Ethoglucid; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Papilloma; Time Factors; Urinary Bladder Neoplasms | 1985 |
7 other study(ies) available for ethoglucid and Local Neoplasm Recurrence
| Article | Year |
|---|---|
INTENSIVE NITROGEN MUSTARD THERAPY WITH ABDOMINAL AORTIC OCCLUSION IN NASOPHARYNGEAL CARCINOMA.
Topics: Adenocarcinoma; Antineoplastic Agents; Aorta; Aorta, Abdominal; Busulfan; Carcinoma; Carcinoma, Squamous Cell; Cerebrovascular Disorders; Chemotherapy, Cancer, Regional Perfusion; Drug Therapy; Ethoglucid; Heparin; Humans; Hypothermia; Hypothermia, Induced; Kenya; Lymphoma, Non-Hodgkin; Mechlorethamine; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasms; Palliative Care; Prognosis; Pulmonary Embolism; Sarcoma; Tourniquets; Toxicology | 1965 |
MANAGEMENT OF ADVANCED NEOPLASMS OF THE MAXILLARY AND ETHMOIDAL SINUSES.
Topics: Antineoplastic Agents; Cyclophosphamide; Ethmoid Sinus; Ethoglucid; Geriatrics; Humans; Maxillary Sinus; Neoplasm Recurrence, Local; Neoplasms; Palliative Care; Paranasal Sinus Neoplasms; Paranasal Sinuses | 1965 |
Prognostic factors influencing survival of patients receiving intravesical epodyl.
Topics: Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Papillary; Drug Administration Schedule; Ethers; Ethoglucid; Humans; Neoplasm Recurrence, Local; Retrospective Studies; Urinary Bladder Neoplasms | 1982 |
Intracavitary Epodyl for multiple non-invasive, highly differentiated bladder tumours.
Topics: Aged; Ethers; Ethoglucid; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Urinary Bladder Neoplasms | 1980 |
Long-term follow-up in patients with superficial bladder tumours treated with intravesical Epodyl.
Topics: Carcinoma, Papillary; Ethers; Ethoglucid; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms | 1979 |
Epodyl in management of noninvasive vesical neoplasms.
Topics: Diathermy; Ethers; Ethoglucid; Female; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms | 1978 |
Intravesical epodyl in the management of bladder tumors: combined experience of the Yorkshire Urological Cancer Research Group.
Topics: Adult; Aged; England; Ethers; Ethoglucid; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Remission, Spontaneous; Urinary Bladder; Urinary Bladder Neoplasms | 1977 |